Clinical trial of KD-FLU in healthy childre
Phase 2
- Conditions
- Prophylaxis of influenza infection
- Registration Number
- JPRN-jRCT2080221413
- Lead Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Healthy childeren
Exclusion Criteria
Known history of influenza or received influenza vaccination within six months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immunogenicity<br>HI antibody titer against antigens
- Secondary Outcome Measures
Name Time Method Immunogenicity<br>Neutralizing antibody titer against influenza viruses